By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Knopp Biosciences 

2100 Wharton Street
Suite 615
Pittsburgh  Philadephia  15203  U.S.A.
Phone: 412-488-1776 Fax: n/a



Company News
Knopp Biosciences And APFED Announce Partnership To Advance Awareness Of Hypereosinophilic Syndromes 9/6/2017 6:43:00 AM
Knopp Biosciences Announces Election Of Biotech Executive Shane Kovacs To Board Of Managers 3/21/2017 6:46:05 AM
Knopp Biosciences Announces Publication Of Eosinophil-Lowering Effects Of Dexpramipexole In Multiple Clinical Trials 3/7/2017 6:29:23 AM
Knopp Biosciences Announces NIH Blueprint Grant Award For Advancing Novel Neonatal Epilepsy Treatments 2/16/2017 6:31:46 AM
Knopp Biosciences Release: Company Receives Key Patent Directed To Ion Channel Activators For Brain Disorders 1/26/2017 9:01:42 AM
Knopp Biosciences Receives Key Patent Directed To Treatment For Hypereosinophilic Syndromes, Asthma, And Other Eosinophilic Diseases 1/4/2017 9:43:20 AM
Calman Prussin, M.D., Joins Knopp Biosciences To Lead Clinical Development Of Dexpramipexole In Eosinophilic Asthma 1/7/2016 1:27:56 PM
Knopp Biosciences Broadens Collaboration With National Institutes of Health (NIH) To Investigate Eosinophil-Lowering Effects Of Dexpramipexole 3/13/2014 8:59:43 AM
Knopp Biosciences And National Institutes of Health (NIH) To Collaborate In Evaluating Dexpramipexole In Patients With Hypereosinophilic Syndrome 1/8/2014 9:37:22 AM
Knopp Biosciences Partners With MMS Holdings, Inc. to Manage Pharmacovigilance Services 8/1/2013 12:50:09 PM